DCTH vs. WRBY, NVCR, LMAT, ENOV, CNMD, SSII, EYE, TNDM, CDRE, and LQDA
Should you be buying Delcath Systems stock or one of its competitors? The main competitors of Delcath Systems include Warby Parker (WRBY), NovoCure (NVCR), LeMaitre Vascular (LMAT), Enovis (ENOV), CONMED (CNMD), SS Innovations International (SSII), National Vision (EYE), Tandem Diabetes Care (TNDM), Cadre (CDRE), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry.
Delcath Systems vs.
Delcath Systems (NASDAQ:DCTH) and Warby Parker (NYSE:WRBY) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, community ranking, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.
Warby Parker received 19 more outperform votes than Delcath Systems when rated by MarketBeat users. Likewise, 46.61% of users gave Warby Parker an outperform vote while only 29.27% of users gave Delcath Systems an outperform vote.
61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 17.9% of Delcath Systems shares are held by insiders. Comparatively, 18.2% of Warby Parker shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Delcath Systems presently has a consensus target price of $24.00, indicating a potential upside of 42.26%. Warby Parker has a consensus target price of $22.88, indicating a potential upside of 7.95%. Given Delcath Systems' stronger consensus rating and higher possible upside, equities research analysts plainly believe Delcath Systems is more favorable than Warby Parker.
Delcath Systems has higher earnings, but lower revenue than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.
Delcath Systems has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Comparatively, Warby Parker has a beta of 2.1, suggesting that its stock price is 110% more volatile than the S&P 500.
Warby Parker has a net margin of -4.39% compared to Delcath Systems' net margin of -150.70%. Warby Parker's return on equity of -8.26% beat Delcath Systems' return on equity.
In the previous week, Delcath Systems had 2 more articles in the media than Warby Parker. MarketBeat recorded 8 mentions for Delcath Systems and 6 mentions for Warby Parker. Warby Parker's average media sentiment score of 1.05 beat Delcath Systems' score of 0.99 indicating that Warby Parker is being referred to more favorably in the news media.
Summary
Warby Parker beats Delcath Systems on 12 of the 18 factors compared between the two stocks.
Get Delcath Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for DCTH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Delcath Systems Competitors List
Related Companies and Tools
This page (NASDAQ:DCTH) was last updated on 6/5/2025 by MarketBeat.com Staff
Buy DCTH Stock Free DCTH Stock Alerts